Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

NCT03106324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Innsbruck University Hospital Innsbruck, Austria
  • LKH Hochsteiermark Leoben, Austria
  • University hospital St. Pölten Pölten, Austria
  • CHU Saint-Pierre Brussels, Belgium
View all 125 locations
View Trial Details
Completed

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

NCT05032820

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 15 locations
View Trial Details
Completed

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma

NCT01222286

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mount Sinai School of Medicine New York, United States
  • Ohio State University Columbus, Ohio, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

NCT02320357

Conditions
Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysgammaglobulinemia, +8 more
Locations
  • Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André Bordeaux, France
  • Service de Médecine Interne Limoges, France
  • Service de Médecine Interne et Immunopathologie Toulouse, France
View Trial Details
Completed

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

NCT01053949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU-Hôpital Sud, avenue Laennec, Amiens, France
  • Hématologie, Hôpital Avicenne Bobigny, France
  • Hématologie, CHU, avenue G.Clemenceau Caen, France
  • Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France
View all 19 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

NCT04093596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Sarah Cannon/Colorado Blood Cancer Institute Denver, Colorado, United States
View Trial Details

Related conditions